This HTML5 document contains 146 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n9http://dx.doi.org/10.1086/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n11http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q43036483
rdf:type
wikibase:Item
schema:description
2002年學術文章 мақолаи илмӣ artikull shkencor 2002年学术文章 vitenskapelig artikkel 2002년 논문 2002年學術文章 bilimsel makale artykuł naukowy scientific article published on 6 February 2002 2002年學術文章 artigo científico teaduslik artikkel наукова стаття, опублікована в лютому 2002 2002年学术文章 articol științific artículu científicu espublizáu en 2002 naučni članak scienca artikolo 2002年学术文章 научна статия 2002年学术文章 مقالة علمية نشرت في 6 فبراير 2002 научни чланак artikulong pang-agham wissenschaftlicher Artikel tieteellinen artikkeli artikel ilmiah bài báo khoa học vědecký článek 2002 nî lūn-bûn 2002 թվականի փետրվարի 6-ին հրատարակված գիտական հոդված ৬ ফেব্রুয়ারি ২০০২-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ videnskabelig artikel wetenschappelijk artikel 2002年学术文章 научни чланак tudományos cikk 2002年學術文章 artigo científico სამეცნიერო სტატია article científic article scientifique scientific article published on 6 February 2002 научная статья vitskapeleg artikkel 2002年の論文 articolo scientifico article scientific מאמר מדעי 2002年学术文章 vedecký článok vetenskaplig artikel 2002年學術文章 artigo científico artículo científico publicado en 2002 scientific article published on 6 February 2002 επιστημονικό άρθρο บทความทางวิทยาศาสตร์
p:P577
wds:Q43036483-A8268DFC-9500-4EA5-87FA-BE23358641B3
wdt:P577
2002-02-06T00:00:00Z
p:P407
wds:Q43036483-80BAB1CD-8B1A-4422-BB14-3200BD8FAD4B
wdt:P407
wd:Q1860
p:P2860
wds:Q43036483-756DFC0D-6AB0-4892-964B-21E4D7D3D529 wds:Q43036483-7756C924-DF67-41A1-A1B5-5C80B13DC998 wds:Q43036483-7C4ADCB3-5AB1-4B5A-A9E9-761F80C5C49F wds:Q43036483-1894C01E-8AD9-4FD9-9063-9CFF1FCD8FF7 wds:Q43036483-425FB221-B987-4B49-8A3D-6A70FAA879EF wds:Q43036483-452D6167-2D33-43C5-BBA7-2795D45BA4FD wds:Q43036483-49FF90AE-4CD9-483B-812E-2AE74953671F wds:Q43036483-4D6318F3-1203-4EA5-B4A2-2BE4BB93D9FD wds:Q43036483-54663404-8434-405F-98E1-C3133BD72D41 wds:Q43036483-C60399EF-D241-4363-BB93-9F59758BB8E9 wds:Q43036483-8B1EBED0-F785-432B-956E-F95CE0A433F8 wds:Q43036483-900C74D1-836E-4F75-8532-03712D555DBF wds:Q43036483-9A83961E-15ED-4FBC-88DE-3AA66A0F0400 wds:Q43036483-9FD09E17-3A86-4EBC-8958-3C8EE28A85C0 wds:Q43036483-ADE1BB8C-CC06-4F4D-A25D-0CF757C0FE3A wds:Q43036483-00DCAC05-1B6B-4F55-B7BE-408B84395F05 wds:Q43036483-0CEE4B1B-F7F2-4F31-91D0-7DDA75BC4419 wds:Q43036483-E220476A-D075-4813-9E0F-A4ECB3F9B71F wds:Q43036483-E7401998-47A0-419E-B67F-9C421EB8C8F3 wds:Q43036483-FA2AD057-AC8B-43CE-A224-9D11D8174B43
wdt:P2860
wd:Q42988073 wd:Q50636839 wd:Q39576918 wd:Q41710040 wd:Q42995922 wd:Q29620136 wd:Q39526550 wd:Q45852327 wd:Q45742051 wd:Q27860949 wd:Q27861083 wd:Q42977005 wd:Q45757553 wd:Q42986438 wd:Q45763735 wd:Q45747079 wd:Q42981279 wd:Q42992891 wd:Q45739390 wd:Q42980783
p:P2093
wds:Q43036483-0FAEAFC5-BC49-4AA2-B101-10904EAD0E63 wds:Q43036483-A54D4EAB-33FC-4F1D-9206-3DD65CA3A18C wds:Q43036483-6CC3EDD8-C856-4AFD-A7C9-C6CF80E0F6A2
wdt:P2093
Kenneth E Sherman Natasa Rajicic Susan D Rouster
rdfs:label
Hepatitis C Virus prevalence among patients infected with Human Immunodeficiency Virus: a cross-sectional analysis of the US adult AIDS Clinical Trials Group Hepatitis C Virus prevalence among patients infected with Human Immunodeficiency Virus: a cross-sectional analysis of the US adult AIDS Clinical Trials Group
skos:prefLabel
Hepatitis C Virus prevalence among patients infected with Human Immunodeficiency Virus: a cross-sectional analysis of the US adult AIDS Clinical Trials Group Hepatitis C Virus prevalence among patients infected with Human Immunodeficiency Virus: a cross-sectional analysis of the US adult AIDS Clinical Trials Group
schema:name
Hepatitis C Virus prevalence among patients infected with Human Immunodeficiency Virus: a cross-sectional analysis of the US adult AIDS Clinical Trials Group Hepatitis C Virus prevalence among patients infected with Human Immunodeficiency Virus: a cross-sectional analysis of the US adult AIDS Clinical Trials Group
p:P50
wds:Q43036483-47DCFC32-5331-4011-811F-E82D70E11A3B
wdt:P50
wd:Q89550138
p:P1476
wds:Q43036483-D44CF122-B92D-4BF6-8B7A-7A42BAA51953
wdt:P1476
Hepatitis C Virus prevalence among patients infected with Human Immunodeficiency Virus: a cross-sectional analysis of the US adult AIDS Clinical Trials Group
p:P304
wds:Q43036483-C54310C0-9DEB-4C28-8B2B-F1E174548A88
wdt:P304
831-837
p:P31
wds:Q43036483-844A9383-3671-4A82-B0C7-8CDBAE879CB9
wdt:P31
wd:Q13442814
p:P921
wds:Q43036483-15782D5F-D5F6-4934-B481-DE80949DE54A wds:Q43036483-D271736A-8948-4E39-8E46-2F683C369CD4 wds:Q43036483-D4DD38E1-D0FC-4B20-A590-4F07A6758DCC wds:Q43036483-D70288BE-7B73-452A-995A-1595831E1AEF
wdt:P921
wd:Q181600 wd:Q808 wd:Q708693 wd:Q154869
p:P698
wds:Q43036483-78A91F0C-7BC5-46A8-80BC-DEB6C37F79FA
wdtn:P698
n11:11833007
wdt:P698
11833007
p:P1433
wds:Q43036483-C5C8223B-A945-4A61-8A2B-8C11113D6FD1
wdt:P1433
wd:Q5133764
p:P433
wds:Q43036483-71553B90-627A-4762-8DF8-8F286840E1CD
p:P478
wds:Q43036483-3821541F-B1A9-4A96-AC4E-2D17367ED69E
wdt:P433
6
wdt:P478
34
p:P356
wds:Q43036483-B817F363-C5B4-4C40-9828-C68D9A2A10A4
wdtn:P356
n9:339042
wdt:P356
10.1086/339042
p:P5875
wds:Q43036483-C77D5F9E-E847-40EA-9004-043C7D4F6C9E
wdt:P5875
11527735